SCHEMBL21212231

SCHEMBL21212231

Cc1cc(N2CCC(C)C2)cc(C)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 5/20 0.43
▸ L3MBTL1 Q9Y468 3/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ GAA P10253 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ ALDH1A1 P00352 5/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ MAPT P10636 2/20 0.41
▸ TDP1 Q9NUW8 2/20 0.41
▸ JAK3 P52333 1/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ HPGD P15428 3/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ TSHR P16473 2/20 0.39
▸ USP2 O75604 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ SMPD3 Q9NY59 2/20 0.38
▸ PDK2 Q15119 1/20 0.38
▸ NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23424019 0.80 HRH4 (0.43) LMNAJAK3MEN1KMT2ATSHR
SCHEMBL26788467 0.80 HRH4 (0.44) JAK3PDK2HRH4
SCHEMBL19563035 0.76 PDK2 (0.40) LMNASMN1; SMN2GAAALDH1A1KDM4E
SCHEMBL16695435 0.75 NOTUM (0.65) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL21285384 0.75 HRH4 (0.49) LMNAL3MBTL1SMN1; SMN2GAAALOX15
SCHEMBL15108582 0.73 KDM4E (0.62) LMNAL3MBTL1SMN1; SMN2GAAALOX15
SCHEMBL19314278 0.73 USP2 (0.47) LMNAL3MBTL1SMN1; SMN2GAAALDH1A1
SCHEMBL803661 0.73 HRH4 (0.54) HRH4
SCHEMBL6667369 0.72 CHKA (0.50) LMNASMN1; SMN2GAAMAPTJAK3
SCHEMBL21711135 0.72 HRH4 (0.37) GAAKDM4EHPGDHSD17B10HRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3856735-B1 FUSED BICYCLIC HETEROCYCLES AS THERAPEUTIC AGENTS UNIV NEW YORK (US) 2023-09-06 — — EP disclosed
WO-2019148005-A1 INHIBITORS OF CBL-B AND METHODS OF USE THEREOF NURIX THERAPEUTICS, INC. (US) 2019-08-01 — — WO disclosed
Send feedback